Natasha Girgis

Natasha Girgis

Company: Cue Biopharma

Job title: Director - Translational Pharmacology


Showcasing CUE-401: A Novel TGF-β/ IL-2 Fusion Protein for the Induction & Expansion of FOXP3+ Regulatory T Cells 4:00 pm

Exploring TGF-β and IL-2 as two key signals for the induction of regulatory T cell populations Developing CUE-401 as a novel TGF-β and IL-2 directed therapy for the selective expansion of regulatory T cells in vivo Unearthing the mechanism of action and the activity of CUE-401 New Data!Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.